Page 7 - உயிர் மருத்துவ கண்டுபிடிப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana
BridgeBio Pharma, Inc and The Lundquist Institute Collaborate to Advance Treatments for Genetically Driven Conditions and Cancers
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.
BridgeBio Pharma, Inc and The Lundquist Institute Collaborate to Advance Treatments for Genetically Driven Conditions and Cancers
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
BridgeBio Pharma Enters Seven Collaborations with University Partners
Share
Rare Daily Staff
BridgeBio Pharma announced seven separate collaborations with top academic and research institutions to support early, promising research in genetically driven diseases and cancers with clear genetic drivers.
BridgeBio announced partnerships with Brown University, GlycoNet, The Lundquist Institute, Oregon Health & Science University, Roswell Park Comprehensive Cancer Center, the University of California, San Diego; and University of California, Davis.
The latest set of deals brings the total number of partnerships between BridgeBio and leading academic and research institutions to 20 to date.
Through the partnerships BridgeBio will:
Collaborate with UC San Diego on identifying research programs with strong potential for therapeutic applications that address areas of unmet need. BridgeBio will potentially sponsor research programs and support the development of identifie
This event has passed.
April 7 @ 12:00 pm - 1:00 pm
Event Description
Until recently, telehealth services were expensive, rarely available, and often of limited scope and quality. But the COVID-19 pandemic forced a rapid, radical expansion.
To promote the adoption of telehealth services, the Office for Civil Rights within the Department of Health and Human Services (HHS) relaxed the requirement that providers communicate with patients through HIPAA-compliant platforms. Health care providers took their services online, and novel platforms connecting patients with providers proliferated. In short order, telehealth became more accessible and less expensive. From general practice specialties, such as family medicine, to highly specialized fields, such as dermatology, patients can now access a variety of services through websites and smartphone apps.
Japan is late bloomer in race to develop COVID vaccine
Researchers say Japan’s slow development of a vaccine against COVID-19 is linked to decades of stagnant public funding for universities resulting from government slashing overall higher education and research budgets to cope with dwindling national revenue.
But the pandemic reversed the situation last year when government grants were expanded to support new projects that are collaborations between universities and drug companies.
“Japan is a late bloomer in the fight to develop a domestic vaccine. But with new public grants extended to researchers, there are breakthroughs for a domestic product that will improve the safety and efficiency of currently available vaccines,” explained Dr Naoto Uemura, head of clinical pharmacology at Oita University Hospital.
vimarsana © 2020. All Rights Reserved.